Porton Pharma Solutions Ltd.

About Porton Pharma Solutions Ltd.

With over 2,600 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics.
Our Process Technology Centers and USFDA/EMA/PDMA/NMPA-inspected Manufacturing Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets, plus over 500 highly skilled scientists and process engineers, all backed by a proven program management system dedicated to seamlessly delivering successful outcomes for your unique project requirements. 
We are committed to be the most open, innovative and reliable pharmaceutical service platform in the world and Enabling public’s early access to good medicines. We constantly strive for excellence, and have been recognized through awards by industry forums and global pharmaceutical companies for our process innovation, supply chain performance and compliance with global Quality and EHS standa...

  • CN
  • 2015
    On CPhI since
  • 3
  • 1000 - 4999
Company types
Contract Service
Contact info
Meet us at

CPhI Worldwide 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Products from Porton Pharma Solutions Ltd.

  • API CDMO Service
  • Biologics CDMO Service

    Product Biologics CDMO Service

    Gene and Cell Therapy Service  Porton provides world-class process development and manufacturing services for DNA plasmids, viral vectors and cell therapeutics e.g. Car-T backed by state of the art laboratories including BSL-2 laboratories high-quality cGMP production assets operated to global regulatory compliance standards with full traceability and controllability.
  • Drug Product CDMO Service

    Product Drug Product CDMO Service

    Synergizing with US site for global clients, Porton has established end-to-end drug product CDMO platform, integrating global experts and formulation development technologies. The core technology team has experience of over 30 years in big pharma companies and drug product industry. The core R&D, technology and production team has over 10-year hands-on experience in R&D, process development, tech transfer and optimization, life cycle management of innovative and generic drugs. Based on QbD principle, Porton pharmatech provides services from process development, through analytical development and IND filling support for global innovators with solving real issues during development and manufacturing and accelerating from clinics to market.

Porton Pharma Solutions Ltd. Resources